Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A28085 | 16487446 | Clin Endocrinol (Oxf) | Associations between liver histology and cortisol secretion in subjects with nonalcoholic fatty liver disease. | 2006 | Details |
| A28086 | 16485039 | J Clin Invest | Reversal of diet-induced hepatic steatosis and hepatic insulin resistance by antisense oligonucleotide inhibitors of acetyl-CoA carboxylases 1 and 2. | 2006 | Details |
| A28087 | 16479931 | Zhong Yao Cai | [TNF-alpha gene expression of NAFLD rat intervened by the extracts of Rizoma Polygoni Cuspidati]. | 2005 | Details |
| A28088 | 16469684 | Clin Gastroenterol Hepatol | Histologic spectrum of nonalcoholic fatty liver disease in morbidly obese adolescents. | 2006 | Details |
| A28089 | 16466828 | J Hepatol | Early diet-induced non-alcoholic steatohepatitis in APOE2 knock-in mice and its prevention by fibrates. | 2005 | Details |
| A28090 | 16464222 | Am J Gastroenterol | Cryptogenic cirrhosis and NAFLD: are they related? | 2006 | Details |
| A28092 | 16454845 | Am J Gastroenterol | Non-alcoholic steatohepatitis: effect of Roux-en-Y gastric bypass surgery. | 2006 | Details |
| A28093 | 16452829 | Keio J Med | Fat paradox in liver disease. | 2005 | Details |
| A28094 | 16448452 | Liver Int | Clinical model for distinguishing nonalcoholic steatohepatitis from simple steatosis in patients with nonalcoholic fatty liver disease. | 2006 | Details |
| A28095 | 16447287 | Hepatology | Nonalcoholic fatty liver disease: from steatosis to cirrhosis. | 2006 | Details |
| A28096 | 16439872 | AIDS | Altered hepatic expression of SREBP-1 and PPARgamma is associated with liver injury in insulin-resistant lipodystrophic HIV-infected patients. | 2006 | Details |
| A28097 | 16436109 | Int J Exp Pathol | Mouse models in non-alcoholic fatty liver disease and steatohepatitis research. | 2006 | Details |
| A28098 | 16432495 | Ann Hepatol | Frequency of increased aminotransferases levels and associated metabolic abnormalities in obese and overweight children of an elementary school in Mexico City. | 2006 | Details |
| A28099 | 16425410 | World J Gastroenterol | Changes in lipid metabolism in chronic hepatitis C. | 2005 | Details |
| A28100 | 16424622 | Indian J Gastroenterol | Vitamin E-based therapy is effective in ameliorating transaminasemia in nonalcoholic fatty liver disease. | 2006 | Details |
| A28101 | 16420507 | Liver Int | Serum cytokine and soluble cytokine receptor levels in patients with non-alcoholic steatohepatitis. | 2006 | Details |
| A28102 | 16420506 | Liver Int | Premature telomere shortening and impaired regenerative response in hepatocytes of individuals with NAFLD. | 2006 | Details |
| A28103 | 16416209 | Dig Dis Sci | Risk factors and ultrasound can predict chronic hepatitis caused by nonalcoholic fatty liver disease. | 2006 | Details |
| A28104 | 16416204 | Dig Dis Sci | Nonalcoholic fatty liver disease treated by gastroplasty. | 2006 | Details |
| A28105 | 16416185 | Dig Dis Sci | Symptoms of obstructive sleep apnea in patients with nonalcoholic fatty liver disease. | 2005 | Details |
| A28106 | 16412031 | Chin J Dig Dis | Pathogenesis of nonalcoholic steatohepatitis (NASH). | 2006 | Details |
| A28107 | 16408478 | Nihon Koshu Eisei Zasshi | Metabolic syndrome from the view point of public health: with special reference to nonalcoholic fatty liver disease. | 2005 | Details |
| A28108 | 16398679 | Pathol Int | Hepatocellular carcinoma with silent and cirrhotic non-alcoholic steatohepatitis, accompanying ectopic liver tissue attached to gallbladder. | 2006 | Details |
| A28109 | 16398154 | Orv Hetil | [The therapeutic effect of metadoxine on alcoholic and non-alcoholic steatohepatitis]. | 2005 | Details |
| A28110 | 16394799 | Eur J Gastroenterol Hepatol | Serum levels of hepatoprotective peptide adiponectin in non-alcoholic fatty liver disease. | 2006 | Details |
| A28111 | 16394091 | J Clin Endocrinol Metab | Increased serum resistin in nonalcoholic fatty liver disease is related to liver disease severity and not to insulin resistance. | 2006 | Details |
| A28112 | 16393299 | Aliment Pharmacol Ther | Review article: Drug therapy for non-alcoholic fatty liver disease. | 2006 | Details |
| A28113 | 16393285 | Aliment Pharmacol Ther | Blood oxidative stress markers are unreliable markers of hepatic steatosis. | 2006 | Details |
| A28114 | 16385259 | J Pediatr Gastroenterol Nutr | Relationship of hepatic steatosis to adipose tissue distribution in pediatric nonalcoholic fatty liver disease. | 2006 | Details |
| A28115 | 16385233 | Alcohol Clin Exp Res | Difference and similarity between non-alcoholic steatohepatitis and alcoholic liver disease. | 2005 | Details |
| A28116 | 16380770 | Saudi Med J | Nonalcoholic fatty liver disease. Correlation with histology and viral hepatitis. | 2005 | Details |
| A28117 | 16378177 | J Gastroenterol | Diagnosing autoimmune hepatitis in nonalcoholic fatty liver disease: is the International Autoimmune Hepatitis Group scoring system useful? | 2005 | Details |
| A28118 | 16376797 | Clin Liver Dis | Nonalcoholic fatty liver disease in children. | 2006 | Details |
| A28119 | 16375767 | Comp Hepatol | The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis. | 2005 | Details |
| A28120 | 16374859 | Hepatology | Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice. | 2006 | Details |
| A28121 | 16374858 | Hepatology | JNK1 but not JNK2 promotes the development of steatohepatitis in mice. | 2006 | Details |
| A28122 | 16369477 | Med Sci Monit | Non-alcoholic fatty liver disease and metabolic syndrome: what we know and what we don't know. | 2006 | Details |
| A28123 | 16366738 | Altern Med Rev | Adverse effects of dietary fructose. | 2005 | Details |
| A28124 | 16357628 | Eur J Gastroenterol Hepatol | Non-alcoholic fatty liver disease in HIV-positive patients predisposes for acute-on-chronic liver failure: two cases. | 2006 | Details |
| A28125 | 16356443 | J Pediatr | Underdiagnosis of pediatric obesity and underscreening for fatty liver disease and metabolic syndrome by pediatricians and pediatric subspecialists. | 2005 | Details |
| A28126 | 16356442 | J Pediatr | Decreased serum adiponectin: an early event in pediatric nonalcoholic fatty liver disease. | 2005 | Details |
| A28127 | 16355018 | Am J Med Sci | Nonalcoholic steatohepatitis and the metabolic syndrome. | 2005 | Details |
| A28128 | 16343057 | Liver Int | Microarray technology in the study of obesity and non-alcoholic fatty liver disease. | 2005 | Details |
| A28129 | 16340230 | Med Princ Pract | Demographic and clinicopathological characteristics of nonalcoholic fatty liver disease in the East-Southeastern Anatolia regions in Turkey. | 2006 | Details |
| A28131 | 16321567 | Hepatol Res | Relationship between in vivo chlorzoxazone hydroxylation, hepatic cytochrome P450 2E1 content and liver injury in obese non-alcoholic fatty liver disease patients. | 2006 | Details |
| A28133 | 16306373 | Diabetes | Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients. | 2005 | Details |
| A28134 | 16293559 | Scand J Gastroenterol | Abnormal glucose tolerance is a predictor of steatohepatitis and fibrosis in patients with non-alcoholic fatty liver disease. | 2005 | Details |
| A28136 | 16284427 | Endocr J | Serum adiponectin, resistin levels and non-alcoholic fatty liver disease in obese children. | 2005 | Details |
| A28137 | 16281268 | J Clin Ultrasound | Sonographic measurement of the thickness of subcutaneous tissues in nonalcoholic fatty liver disease versus other chronic liver diseases. | 2005 | Details |
| A28138 | 16279902 | Am J Gastroenterol | Anti-tissue transglutaminase antibodies in patients with abnormal liver tests: is it always coeliac disease? | 2005 | Details |
| A28139 | 16278034 | J Hepatol | Adult onset type II citrullinemia as a cause of non-alcoholic steatohepatitis. | 2005 | Details |
| A28140 | 16275057 | Hepatol Res | Clinical and pathological features of non-alcoholic steatohepatitis. | 2005 | Details |
| A28142 | 16270401 | World J Gastroenterol | Is adiponectin level a predictor of nonalcoholic fatty liver disease in nondiabetic male patients? | 2005 | Details |
| A28143 | 16270394 | World J Gastroenterol | Association between thrombotic risk factors and extent of fibrosis in patients with non-alcoholic fatty liver diseases. | 2005 | Details |
| A28144 | 16268963 | Aliment Pharmacol Ther | Review article: the treatment of non-alcoholic steatohepatitis with thiazolidinediones. | 2005 | Details |
| A28145 | 16265156 | Nat Clin Pract Gastroenterol Hepatol | Treatment strategies in nonalcoholic fatty liver disease. | 2005 | Details |
| A28146 | 16265100 | Nat Clin Pract Gastroenterol Hepatol | Mechanisms of Disease: pathogenesis of nonalcoholic fatty liver disease. | 2005 | Details |
| A28147 | 16261527 | J Pathol | Amelioration of non-alcoholic steatohepatitis and glucose intolerance in ob/ob mice by oral immune regulation towards liver-extracted proteins is associated with elevated intrahepatic NKT lymphocytes and serum IL-10 levels. | 2006 | Details |
| A28149 | 16259893 | Obes Surg | The comparison of scoring scales for liver biopsy assessment in morbidly obese patients undergoing bariatric surgery. | 2005 | Details |
| A28150 | 16259794 | Ann Clin Biochem | Detection assessment and monitoring of hepatic fibrosis: biochemistry or biopsy? | 2005 | Details |
| A28151 | 16255293 | Rev Prat | [Epidemiology and natural history of cirrhosis]. | 2005 | Details |
| A28152 | 16254258 | Ann Clin Lab Sci | Association between plasma interleukin-18 levels and liver injury in chronic hepatitis C virus infection and non-alcoholic fatty liver disease. | 2005 | Details |
| A28153 | 16252575 | Ceylon Med J | Clinical, biochemical and histological characteristics of a Sri Lankan population of non-alcoholic steatohepatitis (NASH) patients. | 2005 | Details |
| A28154 | 16252194 | Turk J Gastroenterol | Assessment of lipid peroxidation and antioxidant capacity in non-alcoholic fatty liver disease. | 2005 | Details |
| A28155 | 16252180 | Turk J Gastroenterol | Apoptosis and fibrosis in non-alcoholic fatty liver disease. | 2005 | Details |
| A28156 | 16250043 | Hepatology | Insulin resistance: a metabolic pathway to chronic liver disease. | 2005 | Details |
| A28157 | 16249437 | Diabetes | Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study. | 2005 | Details |
| A28158 | 16248953 | Zhonghua Gan Zang Bing Za Zhi | [The expression and the significance of L-FABP and FATP4 in the development of nonalcoholic fatty liver disease in rats]. | 2005 | Details |
| A28159 | 16247633 | Internist (Berl) | [Therapeutic options for nonalcoholic fatty liver disease and steatohepatitis]. | 2005 | Details |
| A28161 | 16245219 | Turk J Gastroenterol | A new marker for lipid peroxidation: serum paraoxonase activity in non-alcoholic steatohepatitis. | 2005 | Details |
| A28162 | 16242203 | Diabetes Res Clin Pract | Psammomys obesus (sand rat), a new animal model of non-alcoholic fatty liver disease. | 2005 | Details |
| A28164 | 16237810 | Eur Rev Med Pharmacol Sci | Fatty liver and drugs. | 2006 | Details |
| A28165 | 16231594 | Eur Rev Med Pharmacol Sci | The treatment of NAFLD. | 2006 | Details |
| A28166 | 16231592 | Eur Rev Med Pharmacol Sci | Steatosis and hepatocellular carcinoma risk. | 2006 | Details |
| A28167 | 16231591 | Eur Rev Med Pharmacol Sci | Steatosis and portal hypertension. | 2006 | Details |
| A28168 | 16231589 | Eur Rev Med Pharmacol Sci | The natural history and risk factors for progression of non-alcoholic fatty liver disease and steatohepatitis. | 2006 | Details |
| A28169 | 16231588 | Eur Rev Med Pharmacol Sci | Hepatic steatosis and vascular disease. | 2006 | Details |
| A28170 | 16231587 | Eur Rev Med Pharmacol Sci | Nutritional aspects in patients with non-alcoholic steatohepatitis (NASH). | 2006 | Details |
| A28171 | 16231586 | Eur Rev Med Pharmacol Sci | Nonalcoholic fatty liver disease: defining a common problem. | 2006 | Details |
| A28172 | 16231585 | Eur Rev Med Pharmacol Sci | Attraction and growing interest for the fatty liver by the scientific associations. | 2006 | Details |
| A28173 | 16226488 | Hepatol Res | Epidemiological aspects of obesity and NASH/NAFLD in Japan. | 2005 | Details |
| A28174 | 16225478 | Aliment Pharmacol Ther | Review article: role of oxidative stress in the progression of non-alcoholic steatosis. | 2005 | Details |
| A28175 | 16225477 | Aliment Pharmacol Ther | Review article: hepatic steatosis and insulin resistance. | 2005 | Details |
| A28176 | 16225476 | Aliment Pharmacol Ther | Iron and insulin resistance. | 2005 | Details |
| A28177 | 16225473 | Aliment Pharmacol Ther | Review article: non-alcoholic fatty liver disease and hepatitis C--risk factors and clinical implications. | 2005 | Details |
| A28178 | 16225472 | Aliment Pharmacol Ther | Review article: the pathogenesis of fibrosis in non-alcoholic steatohepatitis. | 2005 | Details |
| A28179 | 16225470 | Aliment Pharmacol Ther | Review article: the treatment of fatty liver disease associated with the metabolic syndrome. | 2005 | Details |
| A28180 | 16225469 | Aliment Pharmacol Ther | Review article: the metabolic syndrome and non-alcoholic fatty liver disease. | 2005 | Details |
| A28181 | 16225467 | Aliment Pharmacol Ther | Review article: type 2 diabetes and chronic liver disease in the Verona diabetes study. | 2005 | Details |
| A28182 | 16214395 | Hepatol Res | Pathology of nonalcoholic steatohepatitis. | 2005 | Details |
| A28183 | 16212005 | Rev Med Suisse | [Alcoholic and nonalcoholic steatohepatitis: the same disease! II. Management]. | 2005 | Details |
| A28184 | 16212004 | Rev Med Suisse | [Alcoholic and nonalcoholic steatohepatitis: the same disease! I. Diagnosis and mechanisms]. | 2005 | Details |
| A28185 | 16207567 | Clin Liver Dis | Approach to the diagnosis and treatment of nonalcoholic fatty liver disease. | 2005 | Details |
| A28186 | 16205510 | J Pediatr Gastroenterol Nutr | Decreased prevalence of nonalcoholic fatty liver disease in black obese children. | 2005 | Details |
| A28187 | 16203174 | Hepatol Res | The characteristics and natural history of Japanese patients with nonalcoholic fatty liver disease. | 2005 | Details |
| A28188 | 16202646 | Hepatol Res | Hepatitis C as a metabolic disease: Implication for the pathogenesis of NASH. | 2005 | Details |
| A28189 | 16201116 | Hepatogastroenterology | Levels of serum hyaluronic acid, TNF-alpha and IL-8 in patients with nonalcoholic steatohepatitis. | 2005 | Details |
| A28190 | 16198624 | Hepatol Res | Lessons from animal models of NASH. | 2005 | Details |
| A28191 | 16198623 | Hepatol Res | The role of leptin in progression of non-alcoholic fatty liver disease. | 2005 | Details |
| A28192 | 16198621 | Hepatol Res | Clinicopathological significance of oxidative cellular damage in non-alcoholic fatty liver diseases. | 2005 | Details |